SEARCH

SEARCH BY CITATION

The below article in Volume 157, Supplement 1 of Clinical & Experimental Immunology contained errors:

  • • 
    Ballow, M. Clinical experience with Flebogamma® 5% DIF: a new generation of intravenous immunoglobulins in patients with primary immunodeficiency disease. Clinical & Experimental Immunology 2009; 157 (Suppl. 1): 22–5.

Page 23 (third line of the first paragraph of the Product description section), should have said ‘is ≥99%’. Rather than ‘is = 99%’.

Page 23 (sixth line of the first paragraph of the Product description section): should have said ‘contains ≤3 mg/ml’ rather than ‘contains = 3 mg/ml’.

Page 23 (third-from-the-bottom line in the Anti-viral data section), should have said ‘to ≥20 log10’ rather than ‘to = 20 log10’.

Page 25 (third-from-the-bottom phrase, third-from the bottom paragraph from the Discussion section), should have said ‘The overall clearance of prion from the entire process was ≥18.4 log10/ml’ rather than ‘The overall clearance of prion from the entire process was = 18.4 log10/ml’.